Abbott Pharma Limited
Pharmaceutical company involved in trading, manufacturing, and distribution of various drugs and medicines.
2008 | Delhi (India) | Active
Abbott Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 16 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -3.65%
- Profit Growth 20.13%
- Ebitda 1038.71%
- Net Worth 4.44%
- Total Assets 4.22%
About Abbott Pharma
Abbott Pharma Limited (APL) is a Public Limited Indian Non-Government Company incorporated in India on 24 April 2008 and has a history of 16 years and ten months. Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Pankaj Jha, Neetika Goel, and Man Sharma serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24232DL2008PLC177143
- Company No.
177143
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
24 Apr 2008
- Date of AGM
28 Apr 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Healthcare
Pharma
Who are the key members and board of directors at Abbott Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pankaj Jha  | Director | 08-Jun-2018 | Current |
| Neetika Goel | Additional Director | 08-Nov-2024 | Current |
| Man Sharma | Director | 08-Apr-2023 | Current |
Financial Performance of Abbott Pharma.
Abbott Pharma Limited, for the financial year ended 2018, experienced Minor drop in revenue, with a 3.65% decrease. The company also saw a substantial improvement in profitability, with a 20.13% increase in profit. The company's net worth moved up by a moderate rise of 4.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Abbott Pharma?
In 2018, Abbott Pharma had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Delcure Lifesciences LimitedMan Sharma is a mutual person
- Parke Davis Healthcare Limited
Neetika Goel is a mutual person
- Dhanwantri Vedaresearch Llp
Man Sharma is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Abbott Pharma?
Unlock and access historical data on people associated with Abbott Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Abbott Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Abbott Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
